Bioamber (BIOA) Misses Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts BIOA Hot Sheet
Join SI Premium – FREE
Bioamber (NYSE: BIOA) reported Q2 EPS of ($0.58), $0.08 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $342 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on Bioamber (BIOA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
- Primis Financial (FRST) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
